DABIGATRAN TEVA 150 MG

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

DABIGATRAN ETEXILATE AS MESYLATE

Tillgänglig från:

TEVA ISRAEL LTD

ATC-kod:

B01AE07

Läkemedelsform:

CAPSULES

Sammansättning:

DABIGATRAN ETEXILATE AS MESYLATE 150 MG

Administreringssätt:

PER OS

Receptbelagda typ:

Required

Tillverkad av:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Terapiområde:

DABIGATRAN ETEXILATE

Terapeutiska indikationer:

Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

Tillstånd datum:

2020-02-03

Bipacksedel

PATIENT LEAFLET IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s
prescription only
DABIGATRAN TEVA 150 MG
CAPSULES
THE ACTIVE INGREDIENT:
Each capsule of DABIGATRAN TEVA 150 MG
contains:
150 mg dabigatran etexilate (as mesylate)
For information about inactive ingredients see
section 6 – “Additional information”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING
THE MEDICINE.
This leaflet contains concise information about
the medicine. If you have additional questions,
refer to the doctor or the pharmacist.
This medicine has been prescribed for treatment
of your illness. Do not pass it on to others. It
may harm them even if it seems to you that their
illness is similar.
Patient information card:
This
card
contains
important
safety
information, which you need to know before
starting treatment with Dabigatran Teva and
during the treatment with Dabigatran Teva.
The card contains information intended for both
the patient and the healthcare staff. It provides
guidance for patients on how to minimize the
risk of bleeding, which results from treatment
with any of the anticoagulant preparations.
In addition, the card contains personal details
of the patient and information regarding the
medicine Dabigatran Teva for the healthcare
staff. Present this card to any healthcare
professional involved in your treatment.
1. WHAT IS THE MEDICINE INTENDED
FOR?
Dabigatran Teva contains the active ingredient
dabigatran etexilate, which belongs to a group
of medicines called “anticoagulants”.
Dabigatran Teva is intended for adults:
1. For the prevention of stroke and systemic
embolism in adult patients suffering from
irregular heartbeat (atrial fibrillation) that is
unrelated to valve disease.
2. For the treatment of blood clots in the leg
veins (deep vein thrombosis (DVT)) and in
the pulmonary blood vessels (pulmonary
embolism (PE)) and to prevent the recurrence
of blood clots in these blood vessels.
THERAPEUTIC CLASS: anticoagulants.
2. BEFORE USING THE MEDI